Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Timothy Edwin Wilens, M.D.


This page shows the publications co-authored by Timothy Wilens and Daniel Geller.
Connection Strength

  1. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996 Sep; 153(9):1147-53.
    View in: PubMed
    Score: 0.174
  2. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1995 Jan; 34(1):36-44.
    View in: PubMed
    Score: 0.155
  3. Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series. J Atten Disord. 2006 Feb; 9(3):543-9.
    View in: PubMed
    Score: 0.084
  4. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry. 2001 Apr; 158(4):611-7.
    View in: PubMed
    Score: 0.060
  5. Tourette disorder and ADHD. Adv Neurol. 2001; 85:57-77.
    View in: PubMed
    Score: 0.059
  6. Absence of cardiovascular adverse effects of sertraline in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999 May; 38(5):573-7.
    View in: PubMed
    Score: 0.052
  7. Disentangling the overlap between Tourette's disorder and ADHD. J Child Psychol Psychiatry. 1998 Oct; 39(7):1037-44.
    View in: PubMed
    Score: 0.050
  8. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999 Sep; 56(9):842-7.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.